Manufacturing Considerations for an Early-Stage Advanced Therapy Company 

Maximizing an early-stage biopharma’s chances of success starts with the right manufacturing and outsourcing strategy. Many new companies may lack the capital and resources to perform every function in-house; road mapping a strategy that accounts for this, and subsequently identifying the manufacturing partners to fill gaps in expertise or capability, is critical to maximizing their resources and potential for success. 

Jim Watson (Vice President, Project Farma) and Andrew Doppstadt (Manager, Project Farma) co-author this article to shed light on early-stage biopharma companies’ chances of success provided the right manufacturing strategy in “Manufacturing Considerations for an Early-Stage Advanced Therapy Company”. 

To read the article in full, click here! 

Published: August 2022